Approval · Notice of Compliance 26983 · 2021
FLAGYL: Notice of Compliance 26983
Issued November 5, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26983
- Date
- November 5, 2021
- Company
- Odan Laboratories Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the bottle label format for FLAGYL (Metronidazole Capsules; 500 mg) from a multiple sided peel-back label to a single layer standard label.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLAGYL | Not yet assigned | — |
Medicinal ingredients
- METRONIDAZOLE 500 MG per CAP